Further evidence will be necessary before we can see the complete picture, but they show promise as, at the minimum, an adjunct to current therapy, says Esposito
Conroy advises not to wrap the bandage too tightly
130 In summary, insulin promotes the storage of ingested nutrients for the body to be able to utilise these nutrients when needed to generate ATP, and glucagon induces the breakdown of these stored nutrients when the body needs to utilise them during fasting or exercise
(Source: In August 2025 , Viking Therapeutic announced encouraging mid-stage trial results for its experimental oral/injectable weight loss drug VK2735, which achieved up to 12.2% body weight reduction over 12 weeks, through shares dropped due to higher treatment discontinuation from gastrointestinal side effects
That's not a brand claim
Retatrutide works through multiple metabolic pathways rather than a single receptor like semaglutide